Italia markets closed

GMED May 2024 60.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
4,50000,0000 (0,00%)
In data: 10:22AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente4,5000
Aperto4,5000
Denaro2,5000
Lettera6,3000
Prezzo d'esercizio60,00
Scadenza2024-05-17
Min-Max giorno4,5000 - 4,5000
Contratto - Min-MaxN/D
Volume36
Open Interest74
  • GlobeNewswire

    Twenty Years of the NuVasive XLIF Procedure Celebrated at the Society for Minimally Invasive Spine Surgery 2023 Annual Forum

    AUDUBON, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, celebrated twenty years of the NuVasive XLIF procedure at the Society for Minimally Invasive Spine Surgery (SMISS) ’23 Annual Forum. “Very few medical technology innovations have transformed an industry like the NuVasive XLIF procedure. Twenty years of XLIF has produced two decades of unmatched clinical validation, represented by an incredible body of evidence on the re

  • GlobeNewswire

    Globus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023

    AUDUBON, Pa., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it will continue its partnership with EUROSPINE as a silver sponsor and will attend EUROSPINE 2023 held October 4 to 6 in Frankfurt. “As leaders in the musculoskeletal device industry, we are committed to procedurally integrated innovation that enables surgeons to deliver more intelligent surgery,” said Dan Scavilla, chief executive officer at Globus Me

  • GlobeNewswire

    NuVasive Specialized Orthopedics Launches Precice Bone Transport in International Markets

    AUDUBON, Pa., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of NuVasive Specialized Orthopedics’ (NSO) Precice Bone Transport system in targeted regions. The latest addition to the less invasive NSO portfolio is now CE-marked and approved and available in select markets. “The NSO difference is our deep commitment to making complex reconstruction simple and more reproducible,” said Pete Ligo